Newly Arrival Coagulation Of Water - 6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] – JIN DUN

Short Description:

Product Detail

Product Tags

Feedback (2)

We also offer product sourcing and flight consolidation services. We have our own factory and sourcing office. We can provide you with almost every type of product related to our product range for Industrial Water Treatment, 28 Stages Water Purification Process, Water Chlorination System, Since the factory founded, we have committed to the development of new products. With the social and economic pace, we will continue to carry forward the spirit of "high quality, efficiency, innovation, integrity", and stick to the operating principle of "credit first, customer first, quality excellent". We will create a brilliant future in hair production with our partners.

Newly Arrival Coagulation Of Water - 6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] – JIN DUN Detail:

This product is a light yellow film-coated tablet, white or almost white after removing the coating.

Indications
This product is suitable for the treatment of type 2 diabetes.

Monotherapy
This product is used in conjunction with diet control and exercise to improve blood sugar control in patients with type 2 diabetes.

Used in combination with metformin hydrochloride
When metformin hydrochloride alone cannot effectively control blood sugar, this product can be used in combination with metformin hydrochloride to improve blood sugar control in patients with type 2 diabetes on the basis of diet and exercise.

Used in combination with metformin hydrochloride and sulfonylureas.
When the combined use of metformin hydrochloride and sulfonylureas cannot effectively control blood sugar, this product can be used in combination with metformin hydrochloride and sulfonylureas to improve the blood sugar control of patients with type 2 diabetes on the basis of diet and exercise.

Medication restrictions
This product is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.

Specification
(1) 10 mg; (2) 25 mg.

Dosage
Recommended dose.
The recommended dose of this product is 10 mg in the morning, once a day, on an empty stomach or after eating. In patients who tolerate this product, the dose can be increased to 25 mg (see [Clinical Trials]).
In patients with hypovolemia, it is recommended to correct the hypovolemia before starting to use this product (see [Precautions]).

Patients with renal impairment.
It is recommended to evaluate the renal function before starting to use this product, and then it should be evaluated regularly.
Patients whose eGFR is lower than 45 mL/min/1.73 m2 should not use this product.
Patients with eGFR higher than or equal to 45 mL/min/1.73 m2 do not need to adjust the dose.
If eGFR is continuously lower than 45 mL/min/1.73 m2, this product should be discontinued (see [Precautions]).

Patients with liver damage.
Patients with liver damage do not need to adjust the dose. Enpagliflozin exposure increased in patients with severe liver damage. The treatment experience of patients with severe liver damage is limited, therefore, it is not recommended for this part of the population.

Standard：enterprise standard
purity：≥99.0%

Exterior：white to off-white powder
Package： 25kg/drum

Product detail pictures:

Related Product Guide:

We know that we only thrive if we can easily guarantee our combined cost competiveness and high-quality advantageous at the same time for Newly Arrival Coagulation Of Water - 6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] – JIN DUN , The product will supply to all over the world, such as: Canada, Surabaya, venezuela, Taking the core concept of "to be the Responsible". We'll redound up on society for high quality merchandise and good service. We will initiative to participate in international competition to be a first- class manufacturer of this product in the world.

Analgesia For Nerve Pain

Antipsychotic Meds

Colistin Sulfate 1264-72-8

Drilling Fluid Wrapping Agent

Hepatitis Ab And C

Polyamide Epichlorohydrin

Rafoxanide 22662-39-1

Reverse Osmosis Water Purification System

Superhydrophobic Spray

Well Water Treatment Systems

The enterprise has a strong capital and competitive power, product is sufficient, reliable, so we have no worries on cooperating with them.

By Maureen from Bandung - 2017.01.28 18:53

With a positive attitude of "regard the market, regard the custom, regard the science", the company works actively to do research and development. Hope we have a future business relationships and achieving mutual success.

By Sarah from Mombasa - 2017.04.08 14:55

Write your message here and send it to us

Newly Arrival Coagulation Of Water - 6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] – JIN DUN